Suchergebnisse - "Personeni, Nicola"

PubPharm (10)

1

Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma : shedding light on the preclinical rationale and clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Cammarota, A. | Zanuso, V. | D'Alessio, A. | +3

2

The dual checkpoint blockade in unresectable hepatocellular carcinoma : opportunities emerging in clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Cammarota, A. | Zanuso, V. | D'Alessio, A. | +4

3

Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma : Current Insights

enthalten in: Journal of hepatocellular carcinoma | 2022

von Cammarota, A. | Zanuso, V. | Pressiani, T. | +2

4

Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Cammarota, A. | Zanuso, V. | D’Alessio, A. | +3

5

The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Cammarota, A. | Zanuso, V. | D’Alessio, A. | +4

6

Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer : Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Pinato, D. | Marron, T. | Mishra-Kalyani, P. | +39

7

Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma

enthalten in: Expert review of anticancer therapy | 2021

von D'Alessio, A. | Cammarota, A. | Zanuso, V. | +3

8

Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib : a Proof-of-Concept Trial

enthalten in: Molecular imaging and biology | 2020

von Castello, A. | Rimassa, L. | Personeni, N. | +3

9

COVID-19 and liver cancer clinical trials : Not everything is lost

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2020

von D'Alessio, A. | Personeni, N. | Pressiani, T. | +6

10

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

enthalten in: Oncotarget | 2016

von Rimassa, L. | Abbadessa, G. | Personeni, N. | +17

1
[1]